NDAORALTABLET
Approved
Dec 2017
Lifecycle
Peak
Competitive Pressure
8/100
Clinical Trials
1
Clinical Trials (1)
Ertugliflozin and Sitagliptin Co-administration Factorial Study (VERTIS FACTORAL, MK-8835-005)
Started Apr 2014
1,233 enrolled
Type 2 Diabetes Mellitus
Loss of Exclusivity
LOE Date
Oct 21, 2030
56 months away
Patent Expiry
Oct 21, 2030
Patent Records (5)
| Patent # | Expiry | Type | Use Code |
|---|---|---|---|
| 7326708 | Nov 24, 2026 | SubstanceProduct | U-2214 |
| 7326708*PED | May 24, 2027 | — | |
| 8080580 | Jul 13, 2030 | SubstanceProduct | U-2214 |
| 9308204 | Oct 21, 2030 | Product | — |
| 9439901 | Oct 21, 2030 | U-2214 |